DVAX Stock Summary and Trading Ideas (Dynavax Technologies | NASDAQ:DVAX)

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies trades on the NASDAQ stock market under the symbol DVAX.

As of February 10, 2026, DVAX stock price was flat at $15.50 with million shares trading.

DVAX has a beta of 0.44, meaning it tends to be less sensitive to market movements. DVAX has a correlation of 0.02 to the broad based SPY ETF.

DVAX has a market cap of $1.82 billion. This is considered a Small Cap stock.

Last quarter Dynavax Technologies reported $95 million in Revenue and $.21 earnings per share. This beat revenue expectation by $437,900 and exceeded earnings estimates by $.08.

In the last 3 years, DVAX traded as high as $15.73 and as low as $9.20.

The top ETF exchange traded funds that DVAX belongs to (by Net Assets): IJR, VTI, XBI, IWM, VXF.

DVAX has outperformed the market in the last year with a price return of +17.4% while the SPY ETF gained +15.6%. DVAX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +40.4% and +0.1%, respectively, while the SPY returned +1.9% and -0.5%, respectively.

DVAX support price is $15.45 and resistance is $15.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DVAX shares will trade within this expected range on the day.